Sure, but a PR screw up. Aussie biotech company story was a good one and one that is more likely to be supported here in Aus, get some good media coverage, help bring investors etc. Every sale would have helped, our market penetration overseas has been hopeless. I'm not sure the market will take a great deal of interest in the TGA approval now anyway, it's all a bit late and isn't going to solve the underlying issues the company is now facing.
Sure, but a PR screw up. Aussie biotech company story was a good...
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.13 |
Change
-0.220(1.20%) |
Mkt cap ! $352.7M | |||
| Open | High | Low | Value | Volume |
| $18.36 | $18.47 | $18.13 | $30.44K | 1.674K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.35 | 48 | 2 |
View Market Depth
| Last trade - 10.36am 03/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |